US 8637026
Anti-C35 antibody combination therapies and methods
granted A61KA61K2039/507A61K2039/545
Quick answer
US patent 8637026 (Anti-C35 antibody combination therapies and methods) held by VACCINEX, INC. expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VACCINEX, INC.
- Grant date
- Tue Jan 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K2039/507, A61K2039/545, A61P, A61P35/00